Practical commercial advice for life sciences businesses

We support life science tools, reagents and diagnostics companies with M&A, growth strategy, targeted marketing and exit preparation.

We are a life sciences consultancy specialising in mergers and acquisitions, commercial strategy, and marketing services for companies in the life sciences and biotech sectors. Our consultants bring both scientific know-how and commercial expertise to provide consultancy advice and practical help with implementation.

Start a conversation Meet our consultants

biotech strategy consulting team talking to a client

How can we help you?

Running a life science company brings different challenges depending on where you are in your journey. Whether you are planning an acquisition, trying to bring structure to your growth, or struggling to generate consistent marketing material, it can be difficult to know what to prioritise next. We have worked with companies at each of these stages, both as operators and advisors.

Commercial Strategy

Life science companies face complex decisions around product portfolios, sales strategy, routes to market and the competitive landscape.

We assess the business and its market position, align scientific, commercial and financial priorities, then build a practical plan and support its implementation.

→ Explore Consultancy Services

Marketing & Branding

Strong science does not always translate into sales. Your marketing materials need to follow a clear strategy to reach the right people with the right information.

We assess your revenue lines, products and customers to build a marketing strategy all rooted in your brand identity.

→ Explore Marketing Services

Mergers & Acquisition

Selling or acquiring a life science business involves important decisions around timing, value, strategic fit and execution.

We help owners identify suitable acquisition targets, assess commercial fit, prepare transaction materials and make introductions through our sector network.

→ Explore M&A Services

Case Study

From preclinical assets to commercial portfolios, we help biotech companies achieve critical business milestones: faster time-to-market, lower cost of goods, capital-efficient scale-up, and maximized exit valuations. Our expertise delivers measurable commercial impact—across every stage of the development lifecycle.

LEarn MoreContact

2BScientific – Commercialisation and Marketing Support

The Challenge:

As 2BScientific expanded, the business required a structured commercialisation strategy to support growth, strengthen its market position and ensure marketing activity remained aligned with wider business objectives.

Our Approach & Outcome:

Pivotal Scientific developed and implemented the commercialisation and marketing strategy, covering customer targeting, market positioning, content development, digital campaigns and growth planning. Tim Bernard, CEO of Pivotal Scientific, initially acted as Marketing Director, helping establish 2B Scientific’s commercial foundations.

2B Scientific built a recognised brand and stronger presence in life science distribution, supported by scalable marketing infrastructure. PSL continues to support its marketing and long-term growth plans.

Why work with Pivotal Scientific?

As a life science consultancy, we support companies across biotech, research reagents, diagnostics, RUO, and IVD, with services tailored to each business’s needs. We are here to support you every step of the way with:

Expert Team: Our consultants bring more than 90 years of combined real-world experience building, running and advising life science businesses.
Global Network: We have an international network of partners, distributors and industry contacts across the life science sector.
Proven Success: We’ve helped more than 100 life science companies achieve their goals.
Tailored Support: Support can range from focused consultancy projects to ongoing strategic, marketing and commercial support.

Speak to an expert

Introduction For many founders of life science research tool companies, the business is more than a company. It represents years of scientific innovation, persistence, passion and personal sacrifice. It has been their life. Deciding when to exit is therefore one of the most important strategic and personal decisions a founder…

Here is where to start, what to measure, and what to ignore in 2026

How smarter financial oversight leads to stronger valuations, better decision‑making, and long‑term resilience.

Learn how reagent licensing works in life sciences, including RUO vs IVD models

Introduction: Biotechnology Industry Outlook for 2026 Biotech enters 2026 with momentum, as new modalities mature and technological capabilities broaden, with breakthroughs accumulating across oncology, metabolic diseases and neuroscience. More broadly, the biopharmaceutical industry is balancing rapid scientific progress with geopolitical tensions, pricing pressures and regulatory changes that complicate growth strategies…

Introduction: when strong science is not enough Biotech companies rarely design their life science product portfolios through one intentional, planned exercise. Instead, portfolios often grow over time through internal R&D, responding to research trends, or adopting new technologies. Although this organic growth can lead to a scientifically credible catalogue, it…

Introduction When working with life science companies, we often find that they have great technology but can underestimate the importance and challenge of getting that innovation into the hands of customers. Significant time and capital are rightly invested in R&D to secure long-term growth. However, even the most scientifically robust…

Strategic partnership combines AI governance, commercial strategy, and marketing intelligence for biotech companies LONDON, UK / OXFORD, UK – [28th January 2026] – Strivenn, a life science marketing consultancy specialising in AI adoption and go-to-market strategy, today announced a partnership with Pivotal Scientific, a leading biotech consultancy. As part of…

How a Life Science Company Can Leverage Growing Economies Emerging markets represent a significant growth opportunity for life science companies. These regions account for 85 percent of the world’s population and are experiencing rapid expansion in healthcare investment, research, and access to new treatments. As healthcare systems evolve, demand is…

Distributors Are More Than Just Sellers Why the Indirect Sales Model Is More Strategic Than You Think For many life science SMEs, distributors have traditionally been seen as a functional solution: handle fulfilment, move product, cover territory. But that mindset undersells the potential. In the right hands, indirect sales aren’t…

One of the biggest and most disruptive innovations in recent times is that of Artificial Intelligence (AI). In every sphere of modern life AI is having an impact. While some uses of AI, such as automating or improving efficiency in labour-intensive tasks have been welcomed, others have been met with…

The US trade tariffs and science funding cuts – implications for the global life science market. The trade tariffs and science funding cuts made by the Trump administration in the US have been well documented, but what do they mean for the life science community? At Pivotal Scientific our clients…

Life sciences consultancy